These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 17431788)

  • 1. Modeling of microbial population responses to time-periodic concentrations of antimicrobial agents.
    Nikolaou M; Schilling AN; Vo G; Chang KT; Tam VH
    Ann Biomed Eng; 2007 Aug; 35(8):1458-70. PubMed ID: 17431788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mathematical modelling response of Pseudomonas aeruginosa to meropenem.
    Tam VH; Schilling AN; Poole K; Nikolaou M
    J Antimicrob Chemother; 2007 Dec; 60(6):1302-9. PubMed ID: 17913722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae.
    Lee MY; Ko KS; Song JH; Peck KR
    J Antimicrob Chemother; 2007 Oct; 60(4):782-7. PubMed ID: 17681978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of ofloxacin, pefloxacin, and tobramycin on the hydrophobicity of Klebsiella pneumoniae].
    Hostacká A
    Epidemiol Mikrobiol Imunol; 1999 Feb; 48(1):28-30. PubMed ID: 11038674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of rpoS gene and quorum-sensing system in ofloxacin tolerance in Pseudomonas aeruginosa.
    Kayama S; Murakami K; Ono T; Ushimaru M; Yamamoto A; Hirota K; Miyake Y
    FEMS Microbiol Lett; 2009 Sep; 298(2):184-92. PubMed ID: 19645822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic studies in rats with ofloxacin and MF-934, a new fluorinated quinolone.
    Mattina R; Bellotti M; Raimondi A; Sander K
    Chemioterapia; 1987 Jun; 6(2 Suppl):302-3. PubMed ID: 3334569
    [No Abstract]   [Full Text] [Related]  

  • 7. Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY.
    Landman D; Bratu S; Kochar S; Panwar M; Trehan M; Doymaz M; Quale J
    J Antimicrob Chemother; 2007 Jul; 60(1):78-82. PubMed ID: 17490999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simulated comparison of the pharmacodynamics of ciprofloxacin and levofloxacin against Pseudomonas aeruginosa using pharmacokinetic data from healthy volunteers and 2002 minimum inhibitory concentration data.
    Burgess DS; Hall RG
    Clin Ther; 2007 Jul; 29(7):1421-7. PubMed ID: 17825693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An organo-silver compound that shows antimicrobial activity against Pseudomonas aeruginosa as a monomer and plasma deposited film.
    Poulter N; Munoz-Berbel X; Johnson AL; Dowling AJ; Waterfield N; Jenkins AT
    Chem Commun (Camb); 2009 Dec; (47):7312-4. PubMed ID: 20024212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptidomimetics of efflux pump inhibitors potentiate the activity of levofloxacin in Pseudomonas aeruginosa.
    Renau TE; Léger R; Yen R; She MW; Flamme EM; Sangalang J; Gannon CL; Chamberland S; Lomovskaya O; Lee VJ
    Bioorg Med Chem Lett; 2002 Mar; 12(5):763-6. PubMed ID: 11858997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in vitro investigation of levofloxacin and ciprofloxacin against clinical isolates of Pseudomonas aeruginosa.
    Segatore B; Perilli M; Larosa M; Setacci D; Celenza G; Amicosante G
    Int J Antimicrob Agents; 2007 Oct; 30(4):374-6. PubMed ID: 17659863
    [No Abstract]   [Full Text] [Related]  

  • 12. A new modeling approach to the effect of antimicrobial agents on heterogeneous microbial populations.
    Nikolaou M; Tam VH
    J Math Biol; 2006 Feb; 52(2):154-82. PubMed ID: 16195922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance of dormant and active cells in Pseudomonas aeruginosa PA01 biofilm to antimicrobial agents.
    Kim J; Hahn JS; Franklin MJ; Stewart PS; Yoon J
    J Antimicrob Chemother; 2009 Jan; 63(1):129-35. PubMed ID: 19001451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addressing the stability of C-capped dipeptide efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa.
    Renau TE; Léger R; Flamme EM; She MW; Gannon CL; Mathias KM; Lomovskaya O; Chamberland S; Lee VJ; Ohta T; Nakayama K; Ishida Y
    Bioorg Med Chem Lett; 2001 Mar; 11(5):663-7. PubMed ID: 11266165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro pharmacodynamics of moxifloxacin versus levofloxacin against 4 strains of Streptococcus pneumoniae: 1 wild type, 2 first-step parC mutants, and 1 pump mutant.
    Schafer J; Hovde LB; Simonson D; Rotschafer JC
    Diagn Microbiol Infect Dis; 2008 Feb; 60(2):155-61. PubMed ID: 17910998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility of Pseudomonas aeruginosa from dogs and cats as well as Arcanobacterium pyogenes from cattle and swine as determined in the BfT-GermVet monitoring program 2004-2006.
    Werckenthin C; Alesík E; Grobbel M; Lübke-Becker A; Schwarz S; Wieler LH; Wallmann J
    Berl Munch Tierarztl Wochenschr; 2007; 120(9-10):412-22. PubMed ID: 17939456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro infection model characterizing the effect of efflux pump inhibition on prevention of resistance to levofloxacin and ciprofloxacin in Streptococcus pneumoniae.
    Louie A; Brown DL; Liu W; Kulawy RW; Deziel MR; Drusano GL
    Antimicrob Agents Chemother; 2007 Nov; 51(11):3988-4000. PubMed ID: 17846144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of ciprofloxacin and levofloxacin in experimental pneumonia caused by Klebsiella pneumoniae deficient in porins, expressing active efflux and producing QnrA1.
    Rodríguez-Martínez JM; Pichardo C; García I; Pachón-Ibañez ME; Docobo-Pérez F; Pascual A; Pachón J; Martínez-Martínez L
    Clin Microbiol Infect; 2008 Jul; 14(7):691-7. PubMed ID: 18558942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of selected antimicrobials on the viability, endotoxicity and lipopolysaccharide composition of Pseudomonas aeruginosa in vitro.
    Abraham M; Venter P; Lues JF; Ivanov I; de Smidt O
    Int J Antimicrob Agents; 2009 Nov; 34(5):419-23. PubMed ID: 19656661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients.
    Falagas ME; Rafailidis PI; Matthaiou DK; Virtzili S; Nikita D; Michalopoulos A
    Int J Antimicrob Agents; 2008 Nov; 32(5):450-4. PubMed ID: 18768302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.